Long-term exposure (LTE) to Tislelizumab, an investigational anti-PD-1 antibody, in a first-in-human Phase I study Conference Paper uri icon

authors

  • Desai, Jayesh
  • Markman, Benjamin
  • Friedlander, Michael
  • Gan, Hui
  • Horvath, Lisa
  • Townsend, Amanda
  • Millward, Michael
  • Jameson, Michael
  • Yen, Chia-Jui
  • Hou, Ming-Mo
  • Hou, Jeannie
  • Wu, John
  • Liang, Liang
  • Deva, Sanjeev

publication date

  • 2019